Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (11598)	6/12/2018 2:16:38 PM
From: Lynn	Respond to of 12215

Thank you for the pointers. They definitely are appreciated. Besides checking-out that thread, I guess it is time for me to (gulp) figure my way around twitter since there is relevant information there. I did join twitter a few years ago, but admit to only following one thing--the alumni magazine from my university (lol).

To: scaram(o)uche who wrote (11598)	6/12/2018 8:44:42 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 12215

<Lynn, be sure to review comments at twitter. Comments include their not having hit statistical significance on an endpoint that they claimed having hit, and a need for near-term funding... a secondary.> Well, IF price deep much below BVF warrant price (@15/share) I may re-enter trading position. 200M MC (EV) for Aramchol (totality of the data, not single point of view) seems to me too low!